Charles Schwab’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-366,666
| Closed | -$109K | – | 3699 |
|
2023
Q2 | $109K | Sell |
366,666
-235,559
| -39% | -$70.2K | ﹤0.01% | 3347 |
|
2023
Q1 | $260K | Sell |
602,225
-6,588
| -1% | -$2.85K | ﹤0.01% | 3116 |
|
2022
Q4 | $718K | Buy |
608,813
+130,162
| +27% | +$154K | ﹤0.01% | 2890 |
|
2022
Q3 | $1.11M | Buy |
478,651
+154,031
| +47% | +$358K | ﹤0.01% | 2757 |
|
2022
Q2 | $718K | Buy |
324,620
+20,933
| +7% | +$46.3K | ﹤0.01% | 2920 |
|
2022
Q1 | $2.93M | Buy |
+303,687
| New | +$2.93M | ﹤0.01% | 2511 |
|